Voglibose / Metformin Tablets Suppliers & Bulk Manufacturers
Available Forms: Tablets
Available Strengths: (Voglibose 0.2/0.3 mg) + (Metformin 500/850 mg)
Reference Brands: Voglimet, Voglinorm-M, Volibo-M, Vogli-Met(India/Japan)
Category: Diabetes
Metformin reduces hepatic glucose production and increases insulin sensitivity, while Voglibose delays carbohydrate absorption in the intestine by inhibiting α-glucosidase. Together, they effectively control fasting and postprandial blood glucose. This synergistic action improves glycemic control in Type 2 Diabetes, especially in patients with high post-meal glucose spikes.
Product Description:
Voglibose + Metformin combination tablets (0.2/0.3 mg Voglibose with 500/850 mg Metformin) are not approved by the FDA (USA) or EMA (EU) for marketing. Voglibose lacks regulatory approval in both regions due to limited clinical data per Western standards. However, this fixed-dose combination is widely approved and marketed in India, Japan, and other parts of Asia for managing Type 2 Diabetes Mellitus, particularly for postprandial hyperglycemia. Brands like Voglimet, Voglinorm-M, and Volibo-M are common. For sourcing, global B2B buyers can access compliant manufacturers through platforms like Pharmatradz.com.
Voglibose / Metformin Tablets — third party manufacturing & bulk supply
Voglibose / Metformin Tablets is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:
What to include when you enquire
- Destination market — determines which manufacturers hold the right site-level approvals
- First order quantity and estimated annual volume
- Whether you need a registration dossier or the product is already registered
- Packaging, labelling and language requirements
- Incoterms and required shelf life
Manufacturers of Voglibose / Metformin Tablets listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding. Narcotic drugs and controlled substances are supplied strictly against valid import and export permits issued by the competent authorities.
Request a quote for Voglibose / Metformin Tablets →The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Frequently Asked Questions
Voglibose / Metformin Tablets are used to manage type 2 diabetes mellitus. Voglibose slows carbohydrate absorption from the intestines, reducing postprandial blood sugar spikes, while metformin decreases hepatic glucose production and improves insulin sensitivity. This combination provides effective glycemic control, especially in patients who require both post-meal and fasting blood sugar management.
The tablets contain voglibose, an alpha-glucosidase inhibitor, and metformin hydrochloride, a biguanide. Voglibose delays digestion of complex carbohydrates to reduce postprandial glucose rise, and metformin improves peripheral glucose uptake and lowers hepatic glucose output.
Common trade names include Volmet, Voglimet, Metvog, and various generic formulations worldwide.
These combination tablets are manufactured by multiple companies in India, LATAM, and Europe. Key manufacturers include Sun Pharma, USV, and Torrent Pharmaceuticals.
The generic names are voglibose and metformin hydrochloride.
Brand names include Volmet, Voglimet, Metvog, and regional generics.
They are manufactured in GMP-certified pharmaceutical facilities across India, Europe, and Latin America.
Related Products
Pioglitazone Hydrochloride 150Mg Tablet
Strength:
15 mg, 30 mg, 45 mg
Form: Tablets
Reference Brands: Actos (USA)
View Details
Nateglinide
Strength:
60 mg, 120 mg, 180 mg
Form: Tablets
Reference Brands: Starlix (USA)
View Details
Miglitol
Strength:
25 mg, 50 mg, 100 mg
Form: Tablets
Reference Brands: Glyset (USA), Diastabol (EU)
View DetailsQuick Response Guaranteed | Verified Suppliers
